WebJan 1, 2014 · Raynaud’s phenomenon is heterogeneous in clinical expression and impact in all domains of clinical assessment including attack frequency, severity, and symptoms. … WebRaynaud’s Syndrome can be a source of great discomfort, as any sufferer will tell you. A condition characterised by blotchy, discoloured extremities, tingling and pain in the affected areas, as well as numbness and spasming. Raynaud’s Syndrome (or Syndrome Raynaud) is very similar to (and is often confused with) Raynaud’s Disease, and ...
Raynaud Syndrome - Heart and Blood Vessel Disorders - MSD …
Raynaud's Phenomenon (RP) is a disorder characterized by an episodic color change of the extremities in response to cold exposure or emotional stress. It is represented by fingers that have turned white, then blue and finally become red which represent vasospasm, deoxygenation, and reperfusion hyperemia.It affects … See more RP occurs as a primary form on its own or as a secondary form due to an underlying disease . It is referred to as "Raynaud's disease" or "primary … See more The symptoms of RP depend on the severity, frequency, and duration of the blood vessel spasm.These may include: 1. Skin decoloration. 2. Mild tingling and digits' numbness. 3. Pain due to irritation of sensory nerves. 4. … See more The causes of both primary and secondary Raynaud's phenomenon are unknown. It's maybe linked to some blood disorders by increasing blood … See more There is no cure for RP but it can be managed with a proper and well-planed treatment based on the patient's symptoms, age, severity, and overall health. The treatment may include: 1. Avoiding exposure to … See more WebThe Physiopedia charity is supported by organisations that collaborate in various ways to help us in our mission to provide open education for the global rehabilitation professions. … incidence of vitt
Pediatric Raynaud Phenomenon Workup - Medscape
WebDefinition/Description. The term ‘thoracic outlet syndrome’ describes compression of the neurovascular structures as they exit through the thoracic outlet (cervicothoracobrachial region). The thoracic outlet is … WebPhysicians have also reportedly used ACE inhibitors, angiotensin receptor blockers, PTK inhibitors and endothelium receptor antagonists for the treatment of Raynaud’s phenomenon due to their ability to reduce vasoconstriction. Clinical trials have shown that 50 mg losartan daily causes a significant reduction in the frequency of spastic ... WebMay 3, 2024 · Background Migraine is responsible for significant disability and societal burden. Recently, drugs targeting the calcitonin gene-related peptide (CGRP) pathway raised new hopes. CGRP, a potent vasodilator, plays a key role in the pathogenesis of migraine attacks. The deficiency of CGRP is involved in Raynaud’s phenomenon, which consists of … inbody 570 pdf